| answer text |
<p>UK Government funding by the Foreign, Commonwealth and Development Office to Product
Development Partnerships has contributed to 66 new health technologies, including
diagnostics, drugs and vaccines being available for diseases and health threats that
are underserved by commercial markets. These products have reached over 2.4 billion
people around the world. This includes the game changing GenXpert technology to detect
TB in 4 hours compared to several weeks previously. The technology was subsequently
progressed to diagnose Ebola and COVID-19. This technology was developed with our
core support by the Foundation for Innovative New Diagnostics and their partners.
Since 2005, we are also one of the major donors to the TB Alliance, which has developed
new treatments for TB, including the first child-friendly drug regimen and novel treatments
for multi-drug resistant TB, such as Pretomanid, which, in combination with 2 other
drugs, offers a highly effective, shorter and less toxic treatment option.</p><p>The
Foreign, Commonwealth and Development Office is a leading supporter of Product Development
Partnerships, which bring together partners from the public, private and philanthropic
sectors to develop new products in a way that de-links the cost of development from
the final cost of product.</p>
|
|
